APA (7th ed.) Citation

Turck, D., Bresson, J., Burlingame, B., Dean, T., Fairweather‐Tait, S., Heinonen, M., . . . Willatts, P. (2018). NWT‐02, a fixed combination of lutein, zeaxanthin and docosahexaenoic acid in egg yolk and reduction of the loss of vision: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal, 16(1), 1. https://doi.org/10.2903/j.efsa.2018.5139

Chicago Style (17th ed.) Citation

Turck, Dominique, et al. "NWT‐02, a Fixed Combination of Lutein, Zeaxanthin and Docosahexaenoic Acid in Egg Yolk and Reduction of the Loss of Vision: Evaluation of a Health Claim Pursuant to Article 13(5) of Regulation (EC) No 1924/2006." EFSA Journal 16, no. 1 (2018): 1. https://doi.org/10.2903/j.efsa.2018.5139.

MLA (9th ed.) Citation

Turck, Dominique, et al. "NWT‐02, a Fixed Combination of Lutein, Zeaxanthin and Docosahexaenoic Acid in Egg Yolk and Reduction of the Loss of Vision: Evaluation of a Health Claim Pursuant to Article 13(5) of Regulation (EC) No 1924/2006." EFSA Journal, vol. 16, no. 1, 2018, p. 1, https://doi.org/10.2903/j.efsa.2018.5139.